| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/18/2008 | CN101199522A Nimodipine lyophilized emulsion for injection and preparing method thereof |
| 06/18/2008 | CN101199521A Application for preparing therapy antiarrhythmic medicament of Zacopride |
| 06/18/2008 | CN101199512A Hif hydroxylase inhibitors |
| 06/18/2008 | CN101199511A Andrographis lactone self-emulsification capsule of antibacterial antiphlogistic |
| 06/18/2008 | CN101199504A Function of stilbene oxygen acid or salt in preparing antiatheroscloresis medicament |
| 06/18/2008 | CN101199503A Hif hydroxylase inhibitors |
| 06/18/2008 | CN101199502A Hif hydroxylase inhibitors |
| 06/18/2008 | CN101199501A HIF hydroxylase inhibitors |
| 06/18/2008 | CN101199500A Function of stilbene oxygen acid or salt in preparing antiatheroscloresis medicament |
| 06/18/2008 | CN101199341A Weight reduction health-care food and its preparation method |
| 06/18/2008 | CN101199329A Condensed juice and integrated freeze-dried powder of purslane |
| 06/18/2008 | CN100395235C Novel crystalline forms of perindopril erbumine. |
| 06/18/2008 | CN100394962C Application of 'Wang Shi Bao Chi Wan' in preparation of medicine for treating hyperlipemia, high blood viscosity syndrome, high blood sugar and hypertension |
| 06/18/2008 | CN100394929C Ginseng stem leaves general saponin freeze-drying powder injection and its preparation method |
| 06/18/2008 | CN100394924C Application of high permeability medicine composition in preparing pre-nacrosis medicine |
| 06/18/2008 | CN100394917C Bilobanoate oral-cavity disintegrating tablet and preparation method |
| 06/18/2008 | CN100394916C Method for providing nutraceutical or phytoceutical benefits and inhibiting oxidation using cherry derivatives |
| 06/17/2008 | US7388078 Nucleic acids encoding polypeptides having chips activity |
| 06/17/2008 | US7388009 Heterocyclic drugs as enzyme inhibitors for Kinase enzymes or prodrugs |
| 06/17/2008 | US7388005 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo [1,2-a]pyrimidin-5(1H)one derivatives for neurodegenerative disorders |
| 06/17/2008 | US7388004 4-{4-[3-[3-(4-Fluorophenyl)-3-hydroxypropyl]-2-(4-methoxyphenyl)-4-oxoazetidin-1-yl]benzylamino}butane-1-sulfonic acid; antilipemic, antidiabetic and hypoglycemic agents; insulin resistance |
| 06/17/2008 | US7387998 STQ peptides |
| 06/17/2008 | US7387800 Mixture containing plant extract; renin, angiogenesis inhibitor; cardiovascular disorders; antidiabetic agents; liver disorders; gall stones; gastrointestinal disorders |
| 06/17/2008 | US7387797 Compositions derived from Modiolus modiolus and methods for making and using same |
| 06/17/2008 | US7387792 Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration |
| 06/17/2008 | US7387777 Methods of treating hemophilia or von willebrand disease with p-selectin |
| 06/17/2008 | CA2469001C Bioabsorbable sealant |
| 06/17/2008 | CA2444053C Fused bicyclic or tricyclic amino acids |
| 06/17/2008 | CA2439152C Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 06/17/2008 | CA2395193C Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 06/17/2008 | CA2393749C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 06/17/2008 | CA2383114C Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositions |
| 06/17/2008 | CA2309202C Adenosine a1 receptor agonists |
| 06/17/2008 | CA2302347C 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-oles, processes for their preparation and their use for medicaments |
| 06/17/2008 | CA2249446C Irreversible inhibitors of tyrosine kinases |
| 06/17/2008 | CA2188892C Use of an yttrium salt in a compound for the treatment of sensitive skin |
| 06/17/2008 | CA2187162C Dna encoding precursor of interleukin-1.beta. converting enzyme-related cysteine proteinase iii (icerel iii) |
| 06/17/2008 | CA2163361C Therapeutic substituted guanidines |
| 06/17/2008 | CA2067250C Inhibition of padgem-mediated cell binding |
| 06/17/2008 | CA1341575C Tumor necrosis factor (tnf) inhibitory protein and its purification |
| 06/12/2008 | WO2008070780A1 Antagonist antibodies against ephb3 |
| 06/12/2008 | WO2008070741A1 Compositions and methods for enhancing survival and reducing injury under ischemic or hypoxic conditions |
| 06/12/2008 | WO2008070583A2 Thrombopoietin mimetics |
| 06/12/2008 | WO2008070552A2 Inhibitors of protein tyrosine phosphatase for the promotion of physiological cardiac hypertrophy |
| 06/12/2008 | WO2008070313A2 3-(dihydro-1h-pyrazolo [4,3-d] pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use |
| 06/12/2008 | WO2008070117A1 Conjoint therapy for treating fibrotic diseases |
| 06/12/2008 | WO2008069688A2 Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
| 06/12/2008 | WO2008069611A1 N-phenylamide derivative, process for the preparation thereof, and composition for preventing or treating ischemic diseases comprising same |
| 06/12/2008 | WO2008068185A1 Spiro-piperidine derivatives as via receptor antagonists |
| 06/12/2008 | WO2008068159A1 Spiro-piperidine derivatives |
| 06/12/2008 | WO2008067909A2 Urea and sulfamide derivatives as tafia inhibitors |
| 06/12/2008 | WO2008067874A1 Substituted dipyridyl-dihydropyrazolones and use thereof |
| 06/12/2008 | WO2008067871A1 Substituted dihydropyrazolones for treating cardiovascular and haematological diseases |
| 06/12/2008 | WO2008067863A2 Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting mpt |
| 06/12/2008 | WO2008067756A1 3-pyrrolo-cyclohexylene-2-dihydro-indolinone derivatives and uses thereof |
| 06/12/2008 | WO2008067713A1 Compounds having substituted cyclopentane structure, their preparation methods and medical uses |
| 06/12/2008 | WO2008067712A1 Compounds having substituted cyclopropane structure, preparation method and uses thereof |
| 06/12/2008 | WO2008067711A1 Compounds having substituted 4-members ring structure and their medicine uses |
| 06/12/2008 | WO2008067710A1 Substituted cyclohexane compounds, preparation methods and medicine uses thereof |
| 06/12/2008 | WO2008067709A1 Substituted cyclobutane compounds, preparation methods and pharmaceutical uses thereof |
| 06/12/2008 | WO2008067687A1 The salts of imidazol-5-carboxylic acid derivatives, preparation methods and use therrof |
| 06/12/2008 | WO2008067641A1 Composition for improving blood flow in working muscles comprising l-arginine, crataegus extract and artichoke flavonoids |
| 06/12/2008 | WO2008067609A1 Method and composition for reducing reperfusion injury |
| 06/12/2008 | WO2008048084B1 Pharmaceutical combinations for the treatment of dyslipidemia accompanied by high blood pressure |
| 06/12/2008 | WO2008048083B1 Pharmaceutical compositions for the treatment of thromboembolic diseases |
| 06/12/2008 | WO2008007216A3 Psoralea corylifolia plant extracts for treating osteoporosis and the extraction process thereof |
| 06/12/2008 | WO2007148230A3 Grafted polymers and uses thereof |
| 06/12/2008 | WO2007132338A3 IL-1α IMMUNIZATION INDUCES AUTOANTIBODIES PROTECTIVE AGAINST ATHEROSCLEROSIS |
| 06/12/2008 | WO2007110237A3 Amide derivatives and their application for the treatment of g protein related diseases |
| 06/12/2008 | WO2007005879A3 Compositions and methods for the treatment or prevention of disorders relating to oxidative stress |
| 06/12/2008 | US20080140138 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 06/12/2008 | US20080139786 Exposing azo, azide and sulfenate agents to visible or infrared light; use in medical procedures to cause necrosis or apoptosis of tissue |
| 06/12/2008 | US20080139785 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 06/12/2008 | US20080139669 Use of a blood-flow decrease preventing agent in conjunction with insufflating gas |
| 06/12/2008 | US20080139668 Pharmaceutical composition for obovatol for the prevention and treatment of restenosis |
| 06/12/2008 | US20080139664 Anti-glycation agents for preventing age-, diabetes-, and smoking-related complications |
| 06/12/2008 | US20080139645 Tablet form for oral administration of amiodarone hydrochloride or dronedarone hydrochloride; antiarrhythmic agents |
| 06/12/2008 | US20080139636 Adamantane derivatives |
| 06/12/2008 | US20080139633 Estrogen receptor modulators; neurodegenerative disorders; cognitive enhancement |
| 06/12/2008 | US20080139622 Decahydronaphthalene Compounds |
| 06/12/2008 | US20080139621 Thrombocytopenia; administering a thrombopoietin receptor agonist; 4-(2-hydroxyphenyl)piperidin-1-yl-acetic acid; 3-(2-hydroxyphenyl)cyclohexane-carboxylic acid; 3-(3'-{2-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-4-ylidene]hydrazino}-2'-hydroxy-phenyl)cyclohexane-1-carboxylic acid |
| 06/12/2008 | US20080139616 Atherosclerosis; inflammatory diseases, Alzheimer's disease, dyslipidemia, metabolic syndrome; 2-isopropyl-5-phenyl-4-[(4-phenylbutyl)amino]isothiazole-3(2H)-thione 1,1-dioxide for example |
| 06/12/2008 | US20080139613 4-{(1R,3R)-1-(3,5-difluorophenyl)-3-[4-(3-ethyl-5-isopropyl-4H-1,2,4-triazol-4-yl)piperidin-1-yl]butyl}-1-(methylsulfonyl)piperidine; for treatment of CCR5 disease states |
| 06/12/2008 | US20080139612 Chemical Compound |
| 06/12/2008 | US20080139607 Inhibitors of the serine protease PAI-1 (plasminogen activator inhibitor type 1); (3R)-8-(3,4-Difluoro-phenyl)-7-heptyl-5-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyridine-3-carboxylic acid for example; desulfurization to form corresponding 1-(1-carboxyethyl)-1,2-dihydro-2-oxopyridine compound; coadministering |
| 06/12/2008 | US20080139602 e.g. 5-{3-[4-(4-Chloro-phenyl)-4-hydroxy-3,3-dimethyl-piperidin-1-yl]-propylidene}-1-oxy-5,11-dihydro-10-oxa-1-aza-dibenzo[a,d]cycloheptene-7-carboxylic acid; chemokine receptor antagonist; antiinflammatory, antidiabetic agent; antiallergen; arteriosclerosis, asthma, arthritis |
| 06/12/2008 | US20080139599 e.g. 4-[6-(5-methyl-2-phenyloxazol-4-ylmethoxy)-1-oxoindan-5-yl]benzoic acid; antidiabetic and antilipemic agent, obesity; atherosclerosis; coupling benzene derivatives folowed by hydration and alkylation |
| 06/12/2008 | US20080139595 Hetaryloxy-Substituted Phenylamino Pyrimidines as Rho Kinase Inhibitors |
| 06/12/2008 | US20080139593 Administering ambrisentan to subject, wherein, at baseline, time from first diagnosis of the condition in the subject is not greater than about 2 years; pulmonary arterial hypertension (PAH); chronic obstructive pulmonary disease; respiratory system, sleep, developmental and cardiovascular disorders |
| 06/12/2008 | US20080139583 Phosphodiesterase 4 inhibitors |
| 06/12/2008 | US20080139576 5-Substituted 1,1-Dioxo- 1,2,5- Thiadiazolidin-3-One Derivatives |
| 06/12/2008 | US20080139570 e.g. N-[2-(6-{[(3,4-dichlorophenyl)methyl]amino}-2-(4-methoxyphenyl)-3-oxo-4-hydropyridino[2,3-b]pyrazin-4-yl)ethyl]acetamide; antidiabetic agent; abnormal lipid levels, cardiovascular disease, obesity, oily skin conditions, metabolic syndrome |
| 06/12/2008 | US20080139567 Psychological disorders; central nervous system disorders; antidepressants; anxiolytic agents; stress reliever; irritable bowel syndrome |
| 06/12/2008 | US20080139565 Anthranilic Acid Derivatives and Their Use in Treatment of Diseases of Lipid Metabolism, in Particular Dyslipidaemia |
| 06/12/2008 | US20080139560 Ion Channel Modulators |
| 06/12/2008 | US20080139558 Quinolones useful as inducible nitric oxide synthase inhibitors |
| 06/12/2008 | US20080139529 Nervous system, neurodegenerative, psychiatric, sexual, attention deficit, and psychological disorders; cognition activators, antidepressants, anxiolytic agents; alcoholism, drug abuse, traumas, strokes, epilepsy, schizophrenia, autism, and/or Alzheimer's disease treatment |
| 06/12/2008 | US20080139527 Methods for treatment of heart disease |
| 06/12/2008 | US20080139521 Use of Megestrol Acetate for Improving Heart Function and the Treatment of Heart Insufficiency |
| 06/12/2008 | US20080139511 Combination Therapies Employing Ace Inhibitors and Uses Thereof for the Treatment of Diabetic Disorders |